








Note: These instructions accompany the Congenital Syphilis Case Investigation and Reporting 
Form, CDC 73.126, REV. 02-2013. 
 
This reporting form is authorized by law (Public Health Service Act, 42 USC 241, OMB Approval 
No. 0920-0128). Reporting of congenital syphilis cases using this form is required of all sexually 
transmitted disease (STD) project areas receiving STD grant funds from the Centers for Disease 






Congenital Syphilis Case Definition 
 
Reported cases of congenital syphilis (CS) before 1989 were defined and classified on the basis of 
a complex set of clinical and serologic features known as the Kaufman criteria. These criteria were 
developed to help clinicians evaluate the likelihood that an infant or a child had CS. The need for 
clinical  criteria  came  from  the  lack  of  a  widely  available  “gold  standard”  test  to  confirm  the 
diagnosis of CS. Serologic tests for syphilis (STS) alone are not useful for diagnosis. The Kaufman 
criteria, however, were not designed for use as a surveillance case definition. 
 
CDC developed a surveillance case definition for CS in 1988 (subsequently revised in 1996). 
This surveillance case definition differs from the clinical diagnosis of congenital syphilis in 
several important ways. All infants born to mothers who have untreated or inadequately treated 
syphilis are considered potentially infected. (This criterion is based on the 70%-100% chance that 
during the  first  4  years of  infection,  an  untreated  woman  will  transmit  syphilis  to  her  unborn 
baby.*) Asymptomatic infants and stillbirths are included in the case definition. The surveillance 
case definition makes case classification simpler, making comparisons across states and regions 
more reliable. Also, longitudinal follow-up is not required to determine the appropriate case 
classification, so reporting can occur in the immediate post-delivery period. 
 
Another important feature of the surveillance case definition is its emphasis on the mother’s 
history of diagnosis, treatment, and follow-up. The cases defined by this surveillance case 
definition give program planners information on how to improve the STD prevention and prenatal 
care systems to identify and treat pregnant women who have syphilis. Having CS surveillance data 
available to program planners and managers improves our ability to reach high risk women and treat 
their syphilis infections early in pregnancy. The increased sensitivity of the surveillance case 
definition can classify infants as cases who are not infected with syphilis, reflecting the limitations 
of current diagnostic tests. Inclusion of these infants in the surveillance system is accepted, however, 
because they help identify problems in the prevention of CS. Nonetheless, the most recent revisions 
to the CS case report Form 126 were made with the intent of having reported cases more closely 
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This form (CDC 73.126 REV. 02-2013) should be used by health officials who are responsible for 
identifying  the  infants  or  children  of  recently  pregnant  women  who  may  be  infected  with 
Treponema pallidum. The accompanying algorithms (found on the back of the reporting form) are 
provided to assist in determining how a case of CS should be classified for reporting purposes. The 
surveillance case definition remains the “gold standard” for CS case classification. The 
surveillance case definition (appendix) should be used to classify cases into one of the following 
three surveillance categories: confirmed, probable, or syphilitic stillbirth. 
 
 
Finding the Data on Cases of Congenital Syphilis 
 
 
The information needed to determine whether an infant or a child meets the criteria for the 
CDC/Council for State and Territorial Epidemiology (CSTE) surveillance case definition of CS may 
be found in a variety of places: 
 
• The mother’s syphilis reactor file 
• The mother’s hospital record 
• The infant’s or child’s hospital record 
• The infant’s or child’s birth certificate or death certificate 
 
No single record is likely to contain all the information needed; therefore, information should be 
obtained from several sources. For example, the following steps may be taken to evaluate a report of 
a reactive STS obtained at delivery: 
 
• Check the STD program’s reactor file to determine whether the mother had evidence of 
untreated or inadequately treated syphilis before delivery. 
 
• Review  the  mother’s  hospital  and  prenatal  records  for  demographic  information, 
prenatal  care  information,  findings  at  delivery  (e.g.,  genital  lesions,  abnormal 
placenta, or stillborn infant), and serologic test results. 
 
•  Review  the  infant’s  or  child’s  medical  record  for  physical  examination  findings, 




If an STS on the mother or infant at delivery is not routinely performed in hospitals, identifying 
cases that meet the surveillance definition of CS will be more difficult.* Case detection can be 
augmented by: 
 
•  Asking all women who are treated for syphilis whether they have been pregnant during the 
last 12 months and asking about the outcome of the pregnancy. 
•  Comparing fetal death records with the reactor file on a routine basis to identify possible 
syphilitic stillbirths. 
 
Health officials responsible for investigating cases of CS should establish working relationships 
with hospitals having obstetrical services, prenatal clinics, and other providers of health care to 
pregnant women and infants to ensure access to all of these records. 
 
Data for case classification should be available at the time of delivery. Sequential infant titers are 
not required for determining whether an infant or a stillborn meets the surveillance case definition 
of  CS. The results of sequential infant titers do not have any bearing on the case classification 
process for surveillance purposes. 
 
Detecting cases of CS is an active process. Someone in the STD prevention program should be 
trained to collect the data necessary for completing this form. In areas where numerous case 
investigations take place, it may be beneficial to request the assistance of the hospital’s infection 
control nurse, obstetricians, midwives, or pediatricians to provide some of the information needed 
to complete the case investigation. 
 
Some data required on the reporting form may not be found on the aforementioned records. 
Names of cities, counties, states, and countries should be entered on the reporting form as numeric 
codes called FIPS (Federal Information Processing Standards) codes. For details on ordering the 
complete Worldwide Geographic Location Codes, call (202) 219-0077 or search for "Geographic 
codes" box on website  WWW.GSA.GOV.FIPS.  Codes should be available for all health care workers 
responsible   for   completing   these   forms.   To   order   copies   of   the   Congenital   Syphilis   Case 
Investigation   and   Reporting   Form   (CDC   73.126)   and/or   Instruction   booklets   contact   the 

















*In  high  syphilis  incidence  areas,  obtaining  a  STS  on  every  mother  or  infant  at  delivery  is  an 
important case detection strategy. If this policy is not in place, STD prevention programs should 






Read the instructions, the footnotes, and the algorithm carefully before attempting to complete 
this form. Before these forms are sent by the local reporting areas to the state health department or 
state STD program, they should be checked for completeness and accuracy by someone familiar 
with the revised 73.126 (02-2013) form and instructions. Errors and omissions should be corrected 
before the form is sent to the state. Similarly, the state STD program should assign someone the 
responsibility of checking forms for completeness and accuracy before sending them to CDC. 
Reporting areas with errors or omissions will be contacted for correct information. The second 
(blue) sheet of the triplicate form should be sent to CDC. Photocopies must have a unique ID and 
should not include the top portion (personal identifiers) of the form. 
 
Individual reports should be sent as soon as possible after the case has been reported to the health 
department.   However, completed  forms  may  be  sent as  batches  to  CDC  monthly.  Morbidity  is 
counted based on the infant’s birth date and the mother's residence. Health departments will be 
given sufficient advance notice of year-end close-out dates. 
 
 
Electronic Reporting of Cases 
 
 
Many  states  are  capable  of  transmitting  the  information  on  the  reporting  form  to  CDC 
electronically   through   the   National   Electronic   Telecommunications   System   for   Surveillance 
(NETSS). The reporting form has been designed to be compatible with NETSS to facilitate this 
method of reporting. Specific instructions for reporting all STD data, including CS data, through 
NETSS is available through the Surveillance and Data Management Branch, (404) 639-8356. 
 
 
Updating Information on a Case Already Reported to CDC 
 
 
To avoid the possibility of duplicate reporting, do not complete a new form to update information 
on a case that has already been reported to CDC. Similarly, do not send a photocopy of the original 
form.   Call   the   Surveillance   and   Data   Management   Branch   (404)   639-8356   regarding   any 
corrections to be made. Methods for updating or correcting cases sent electronically via NETSS will 
be provided in the NETSS instructions. 
 
 
Obtaining Training and In-Service Materials 
 
 
To accurately carry out a case investigation and complete the CS case investigation and reporting 
form requires some epidemiologic and clinical knowledge of CS. The following is a list of recent CDC 
publications  that  describe  CS,  its  diagnosis,  and  treatment.  These  publications  can  be  ordered  by 
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1.   Use a pencil or ballpoint pen to complete forms. Avoid felt tip markers since they result in 
poor copies. 
 
2.   Avoid stacking forms when writing on them; this practice results in extraneous marks on 
copies, making them illegible. 
 
3.   Fill in one digit per dashed line. 
 
4.   Mark only one box per question. 
 
5.   Boxes should preferably be marked with an X. 
 
6.  Dates should be written in MM/DD/YYYY format. Months and days less than 10 should be 
preceded with a zero (0).   For example, May should be recorded as 05. If the day is not 
known, record the known month and year values and record the day as 15. If the entire date 
is unknown, mark the unknown box with an X. 
 
7.   On all questions, unknowns should be marked with an X in the unknown (unk) box. 
 
8.  Do not write in more dates than there are places to write in dates. These dates will be 
disregarded at CDC. 
 
9.  Do  not  write additional  information  in the margins or  spaces.  This  information will be 
disregarded at CDC. For example, if a test result is pending, indicate that the result is 
unknown. Do not write pending in the margin. 
 
10. Skip patterns are directions that appear in bold italic print next to some answers (Go to 
Q...) and direct you to the next question to be answered. Observe these directions and do 
not complete a question that you have been directed to skip. Data entered where an item 
should have been skipped will be disregarded at CDC. 
 
11.  Except for skip patterns and where specifically mentioned in these instructions, all questions 
must be completed. Reporting areas with missing data will be contacted for correct 
information. 
 
12. Footnotes mentioned in these instructions and on the reporting form are located on the back 
of each form. 
 
Reporting Form Items 
 
 
Other geographic unit:  The geographic unit is an optional code such as a census tract identifier or 
the last three digits of the zip code which would be useful to the health department. Leave this 
answer blank if there is no geographic unit. 
 
Case ID No.:  The case identification number is a red preprinted number assigned to each case by 
CDC. 
 
Local Use ID No.:  The local use identification number is an identification number assigned to the 
case by the local or state health department for internal use. Completion of this item is optional. 
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NOTE: Please fill in all fields. If data are unknown, please check the “unknown” (unk) 
box provided  with  the  data  element,  or  code  as  instructed or that  particular data 
element. 
 
Part I. Maternal lnformation 
 
1.        Report Date to Health Department: This is the date when the first information about the 
infant or child came to the attention of the health department or STD program. This field 
should never be blank. If the date is not known, mark the unknown box. The report date 
should never be before the infant’s delivery date. 
 
2–3. Reporting State FIPS code, Reporting County FIPS code: Federal Information Processing 
Standards (FIPS) codes are assigned for each state and county in the United States. State FIPS 
codes are 2-digit numbers and county FIPS codes are 3-digit numbers. Every locality has 
assigned FIPS codes with one exception: U. S. territories do not have assigned county FIPS 
codes. For the purposes of completing this form, U. S. territories should use county FIPS code 
001 and write no county next to this code. The full name of the state and county should be 
written on the line next to each FIPS code. (See the Finding the Data on Cases of Congenital 
Syphilis for instructions on how to obtain FIPS code listings.) 
 
The reporting state and county are where the case report originates. This information should 
never be marked unknown. A case may be investigated in one locality but reported by another. 
In most instances, the patient’s residence is chosen as the reporting locality: however, no 
guidelines exist for designating the reporting locality. To optimize national reporting, each 
area should have a consistent procedure for avoiding reports from both places. 
 
4. Mother’s state FIPS code: This code should correspond to the state of residence of the mother. 
Residence  FIPS  codes  may  be  different  from  the  FIPS  codes  of  the  reporting  health 
department. (See instructions for completing the reporting FIPS codes.) 
 
5. Country of residence: This code should correspond to the country of residence of the mother. 
It  should  be  left  blank  if  the  mother's  residence  is  in  the  U.  S.  For  foreign  countries  of 
residence, enter the 2-digit country code (i.e., CH for China, MX for Mexico, RS for Russia). 
For other country codes, contact the SDMB in the Division of STD Prevention at (404) 639- 
8356. 
 
6. Mother’s residence county FIPS code: This code should correspond to county of residence of 
the mother. Residence FIPS codes may be different from the FIPS codes of the reporting 
health department. (See instructions for completing the reporting FIPS codes.) 
 
7. Mother’s residence ZIP code: Write the zip code of mother’s residence. If the zip code is not 
known, mark the unknown box. 
 
8. Mother’s date of birth: Write the mother’s date of birth. If this date is not known, mark the 
unknown box. 
 
9. Mother’s obstetric history: Write the number of times the mother has been pregnant (G) and 
how many times the mother delivered a live infant (P). Two spaces have been provided in case 
the mother has had more than 9 pregnancies. Elective terminations (abortions) and stillbirths 
would count as pregnancies, but not as deliveries of live births. If mother’s obstetric history is 
not available, enter “99” for both G and P. 
9 
 
10.  Last menstrual period (LMP) (before delivery): Show the date of onset of the last menstrual 
period before delivery.  Do not leave this field blank.  If the LMP is not known, mark the 
unknown box. If the day is not known, record the known month and year values and record 
the day as 15, per General Instruction 6. (see p. 8). 
 
11.  Date of first prenatal visit: 
a)   Show  the date  of the first  prenatal  visit;  do  not  leave  this  field  blank.  If  the  mother 
received no prenatal care, mark the “No prenatal care” box and go to Q12. If the date is 
unknown, mark the “unknown” box and go to Q11b and mark the trimester of the first 
prenatal visit if the mother did have prenatal care. 
b)   Check  the  box  that  matches  the  trimester  of  the  mother’s  first  prenatal  visit.  If the 
prenatal visit is unknown, mark the “unknown” box. 
 
12. Mother’s ethnicity: Mark the appropriate box to denote the mother’s ethnicity Hispanic/Latino 
or Non-Hispanic/Latino). Do not leave this field blank. If mother’s ethnicity is not known, 
mark the “unknown” box. 
 
13. Mother’s race: Mark all that apply to denote the mother’s race: If the mother’s race is 
not known, mark the “unknown” box. 
 
14. Did mother have non-treponemal or treponemal tests at: 
a)   Indicate   if   mother  had non-treponemal or treponemal tests at her first prenatal visit. If 
unknown, mark the “unk” box. 
b)  Indicate if mother had non-treponemal or treponemal tests at 28–32 weeks gestation. 
If  unknown, mark the “unk” box. 
c)   Indicate if mother had  non-treponemal or treponemal tests at delivery. If unknown, mark 
the “unk” box. 
 
15. Mother’s marital status:  Mark the appropriate box to show the mother’s current marital status. 
Do not leave this field blank. If the marital status is not known, mark the “unknown” box. 
 
16. Indicate, during pregnancy and delivery, dates and results of non-treponemal tests: 
a) Write the date of mother’s non-treponemal test at delivery (or closest to it) during the 
pregnancy of the potential case of CS being reported. If the date is unknown, mark the 
“unknown” box. Mark the box that indicates if the test result was reactive or nonreactive; if 
the result is unknown, mark the “unknown” box. If reactive, fill in titers in spaces provided 
beginning   immediately  to   the   right   of   the  colon.   For   example,   a  titer   of   1:8   is 
recorded 1:8_ _ _. Do not fill in the remaining spaces. Rewriting a 1: is not necessary. If 
titer is unknown, write “9999”. If titer exceeds 4 digits, write “8192” (the highest serial dilution
                with 4 digits).  If the titer is weakly reactive then enter (0) zero. 
                      b)    Write the date of mother’s first non-treponemal test for this pregnancy; fill as described for 
                        part a). 
 
                           NOTE: Every date entered in question 16 must have a r esult. Do not enter a result without a date. If there         
                          is a titer, then there must be a response for the date and the result. 
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17. Indicate, during pregnancy and delivery, date, type, and result of treponemal test: 
a)  Write the date of mother’s first treponemal test during the pregnancy of the potential case of 
CS  being  reported.  If  the  first  treponemal  test  was  at  delivery,  list  it  as  the  first 
treponemal test (instead of the test closest to delivery).  If the date is unknown, mark the 
“unk” box. Mark the box that indicates  what  type  of  treponemal  test  (EIA,  TP-PA, 
etc.)  was  used;  if  the  test  type  is unknown,  mark  the  “unk”  box.  Mark  the  box 
that   indicates   if  the   test   result   was reactive or nonreactive; if the result is unknown, 
mark the “unk” box. 
  b)  Write the date of mother’s most recent (e.g., closest to delivery) treponemal test; fill as 
described for part a). 
 
NOTE: Every date entered in question 17 must have a result.  Do not enter a result without a  
date.  If there is a titer, then there must be a response for the date and the test type. 
 
18. What was mother’s HIV status  during pregnancy?:  Please note:  a medically  
documented test result for HIV status is preferred in answering this question;  
if a medically documented test result is not available, use the mother’s responses.  If positive, 
mark the box labeled “P”. If negative, mark the box labeled “N”. If the result was equivocal,  
mark the box labeled “E”. If the mother was asked, and she did not know her HIV test result,  
and no further information is available, mark the box labeled “U”.  If the mother was asked,  
and she stated she has not yet been tested for HIV, and no further information is available,  
mark the box labeled “X”.  
 
19. What CLINICAL stage of syphilis did mother have during pregnancy?:    Mark the box  
that matches the stage of syphilis  with which  a medical provider diagnosed  the mother.  If   
the mother is diagnosed as being “serofast” or having been previously treated for syphilis, mark  
the box labeled “previously treated/serofast”. If the mother is diagnosed with “syphilis” without 
 stage specified, mark the box labeled “Other”. If the stage of syphilis with which a medical  
provider diagnosed the mother is not known or available, mark the box labeled “unk”. 
 
20. What SURVEILLANCE stage of syphilis did mother have during pregnancy?:  Mark the 
box  that  matches  the  surveillance  case  definition  that  best defines the  mother’s  stage 
of syphilis based upon available information. If not enough information is available to match 
a surveillance case definition, mark the box labeled “Other”. If no information is available 
to match a surveillance case definition, mark the box labeled “unk”. 
 
21. When  did  mother  receive  her  first  dose  of  benzathine  penicillin?: Write  the  date 
the mother received her first dose of benzathine penicillin. If the mother’s first dose of benzathine 
penicillin was  before  the  pregnancy  of  the  potential  case  of  CS  being  reported,  mark  the 
box  labeled “Before pregnancy”. If mother’s first dose was during 1st, 2nd, or 3rd  trimester,  
mark the box that matches the trimester. If the date is unknown or mother was treated with  
an antibiotic other than benzathine penicillin, mark the box labeled “unk” and go to Q22. 
If mother  received  no treatment for syphilis, mark the box labeled “No Treatment” and 
go to Q24. 
 
22. What   was   mother’s   treatment?:   Mark   the   box   matching   mother’s   total   dose  
of benzathine  penicillin.  If  mother  was  treated  with  an  antibiotic  other  than   
benzathine penicillin, mark the box labeled “Other”. If the antibiotic with which mother was  
treated is unknown, mark the box labeled “unk”. 
 
23. Did mother have an appropriate serologic response?:   Refer to Footnote B: if mother  
had a 4- fold or greater decrease in nontreponemal titer by 6–12 months after treatment 
for primary or secondary syphilis, or by 12–24 months for latent syphilis (early, late, or of  
unknown duration), mark the box labeled “Yes, appropriate response”. If mother demonstrated  
a 4-fold or greater increase in nontreponemal titer or otherwise showed syptoms of syphilis (e.g., 
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chancre) after treatment, mark the box labeled “No, inappropriate response: evidence of 
treatment failure or reinfection”. If titer changed less than 4-fold, or not enough data are 
available (e.g., only pre- treatment titer available), mark the box labeled “Response could not be 
determined from available non-treponemal titer information”.  If no titers are available 3 or 
more months after treatment, mark the box labeled “Not enough time for titer to change”. 
 
 




24. Date of delivery:  Write the date of delivery of the infant/child (infant’s/child’s birthdate). 
Do not leave this field blank. 
 
25. Vital status:   Show the vital status of the infant/child at the time of this case report and 
investigation. Do not leave this field blank. If the infant or child is alive, proceed to question 27. 
If the infant or child was born alive then died, proceed to question 26. If the infant was stillborn 
(see Footnote C for definition of a stillbirth), proceed to question 27. If the vital status is not 
known, proceed to question 27. 
 
26. Indicate date of death:  Complete this question only if the infant/child died after birth. If the 
date of death is not known, mark the “unk” box. Do not complete this question if the infant was 
stillborn. 
 
27. Birthweight:  Write the birth weight in grams, not pounds and ounces or kilograms. Do not use 
decimal points. Write a 0 in the first space if the infant weighed less than 1000 grams. For 
example, a birth weight of 750 grams should be written as 0 7 5 0. If the hospital recorded the 
weight in pounds and ounces, convert the weight to grams using the formula: 1 pound = 454 
grams, 1 ounce = 28 grams. For example, a birth weight of 6 pounds, 11 ounces = 3,032 grams. If 
the weight is listed in kilograms, multiply kilograms x 1000 = grams. For example, 2.5 kilograms 
= 2500 grams. Do not leave this field blank. If the response is not known, mark the “unk” box. 
 
28. Estimated gestational age (EGA):  Show the gestational age in weeks. If a fraction of a week is 
also recorded, round the gestational age to the nearest whole number. Round down fractions 
of 3/7 or less; round up fractions of 4/7 or more. For example, 40 2/7 weeks should be recorded 
as 40. Gestational age is usually available in the delivery record or can be calculated from the 
maternal due date. The Dubowitz exam (done by hospital staff) or sonogram results are 
acceptable if the LMP or the due date is not recorded. If the infant is called term  without  a 
specified  number  of  weeks,  LMP,  or  due  date,  then  show  the  estimated gestational age as 
40. Do not leave this field blank. If the gestational age is not known, mark the “unk” box. 
 
NOTE: If the infant was stillborn, proceed to Question 37. Do not answer questions 29–36. 
 
29. Did infant/child have a reactive non-treponemal test for syphilis?: (e.g., VDRL, RPR) 
a) Mark the appropriate box to show whether the infant/child has had any reactive non- 
treponemal tests for syphilis at any time. Cord blood tests are included as infant serologic 
tests for syphilis. Do not leave this field blank (unless the infant was stillborn). If the answer 
to this question is “no”, “no test”, or “unknown”, proceed to question 30. If the answer to this 
question is “yes”, fill in: 
b) the date and 
c) the titer of the infant/child’s first reactive non-treponemal test for syphilis. For titer, fill in 
the spaces beginning immediately to the right of the colon. For example, a titer of 1:8 is 
recorded 1:8 _ _ _. Do not fill in the remaining spaces with 9s or 0s. Rewriting a 1: is not 
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necessary. If titer exceeds 4 digits, write “8192” (the highest serial dilution with 4 digits). If 
the titer is unknown, write “9999”.  If the titer is weakly reactive then enter (0) zero.
 
 
30. Did infant/child have a reactive treponemal test for syphilis?: (see Footnote D for details) 
a) Mark the appropriate box to show whether the infant/child has had any reactive treponemal 
tests for syphilis at any time. Cord blood tests are included as infant serologic tests for 
syphilis. Do not leave this field blank (unless the infant was stillborn). If the answer to this 
question is “no”, “no test”, or “unknown”, proceed to question 31. If the answer to this 
questions is “yes”, fill in: 
b) the date of the infant/child’s first reactive treponemal test for syphilis. 
 
31. Did the infant/child, placenta, or cord have a darkfield exam, DFA, or special stains?: Mark the 
appropriate box to show whether a darkfield examination, DFA-TP, or special stain was done 
and the result. Please note: The DFA-TP is not the FTA-ABS. A DFA test is performed on lesion 
material using a fluorescent stain for T. pallidum; it is not a serologic test. Do not leave this 
field blank (unless the infant was stillborn). If the result of the darkfield or DFA-TP examination 
is not known or it is not known whether a darkfield or DFA-TP examination was done, mark the 
“unk” box. 
 
32. Did the infant/child have any signs of CS? (check all that apply): Refer to Footnote E for a list of 
“classic” signs of CS. If physical exam was normal, check “no signs/asymptomatic”.  If no 
information is available, check “unk”. 
 
33. Did the infant/child have long bone X-rays?:  Mark the appropriate box to show whether long 
bone X-rays were done and the results. Evidence of osteochondritis or periostitis is consistent 
with CS. Do not leave this field blank (unless the infant was stillborn). If the results of the long 
bone X-rays are not known or it is not known whether long bone X-rays were done, mark the 
“unk” box. 
 
34. Did the infant/child have a CSF (cerebrospinal fluid) VDRL?: Mark the appropriate box to show 
whether a CSF-VDRL was done and the results. Do not leave this field blank (unless the infant 
was stillborn). If the result of the CSF-VDRL is not known or it is not known whether a CSF 
VDRL was done, mark the “unk” box. 
 
35. Did  the infant/child have a CSF WBC  (white blood  cell)  count  or CSF protein test?:    (See 
Footnote F for a discussion of normal and abnormal CSF WBC count and CSF protein). Mark 
the appropriate box to show whether a CSF WBC count and/or CSF protein test were done, and 
the results. Note that results are recorded as “elevated” or “not elevated”.  Do not leave this field 
blank (unless the infant was stillborn). If the results of the CSF WBC count and CSF protein test 
are not known, or it is not known whether the CSF WBC count and protein were done, mark the 
“unk” box. 
 
36. Was the infant/child treated?:  Mark the appropriate box to show whether treatment was given 
and what was administered.  Mark box 1 if aqueous or procaine penicillin or some combination 
of the two was administered at the recommended dose for 10 or more days.  Previously, box 2 
referred to treatment with ampicillin (usually in combination with an aminoglycoside or 
cephalosporin  for  broad  spectrum  coverage)  and  then  was  switching  to  either  aqueous  or 
procaine penicillin or a combination to complete at least 10 days of therapy. This treatment is no 
longer recommended and is thus obsolete.  Mark box 3 if the infant/child was treated once with 
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benzathine  penicillin  G,  50,000  units/kg  IM.  Mark  box  4  if  a  treatment  other  than  the 
treatments  designated  in  boxes  1  or  3  was  given;  for  example,  10  days  of  ampicillin  or 
ceftriaxone, or other than the recommended dose or duration of penicillin. Mark box 5 if the 
infant/child did not receive therapy.  Mark box 9 if the type or the duration of treatment is not 
known or if it is not known whether treatment was given at all. 
 
 




37. Classification:  For assistance in making a case classification, see the surveillance case definition 
(appendix) and algorithms (decision tree) on the back of the triplicate form of the Case Investigation 
and  Reporting  Form.    Mark  the  appropriate  box  to  show  the  classification:  not  a case, a 





Surveillance Case Definition for Congenital Syphilis 
 
 
A confirmed case of congenital syphilis is an infant or child in whom Treponema pallidum 
is  identified  by  darkfield  microscopy,  direct  fluorescent  antibody,  or  other  specific  stains  in 
specimens from lesions, placenta, umbilical cord, or autopsy material. 
 
A probable case of congenital syphilis is either of the following: 
 
1 
A.  any infant whose mother  had  untreated  or inadequately treated 
delivery, regardless of the findings in the infant or child; 
 
syphilis  at the time of 
 
B. any infant or child who has a reactive treponemal test for syphilis and any one of the 
following: 
2 
1. evidence of congenital syphilis on physical examination ; 
 
2.   evidence of congenital syphilis on long bone X-ray; 
 
3.   reactive cerebrospinal fluid CSF-VDRL; 
 
3 
4.   elevated CSF cell count or protein (without other cause) ; 
 
4 
5.   reactive test for IgM antibody . 
 
 
A syphilitic stillbirth is defined as a fetal death in which the mother had untreated or 











Signs of CS in an infant or a child younger than 2 years of age may include condyloma lata, snuffles, 
syphilitic skin rash, hepatosplenomegaly, jaundice due to syphilitic hepatitis, pseudoparalysis, or edema from 
nephrotic syndrome or malnutrition. Stigmata in an older child may include interstitial keratitis, nerve 
deafness, anterior bowing of shins, frontal bossing, mulberry molars, Hutchinson’s teeth, saddle nose, 
rhagades or Clutton’s joints. 
 
3 
In the immediate newborn period, interpretation of these tests may be difficult; normal values differ with 
gestational age and are higher in preterm infants. CSF cell count and protein in a neonate should be 
3 
interpreted by a clinician. Beyond the neonatal period, a CSF count > 5 wbc/mm 
is abnormal. 
or CSF protein > 40 mg/dl 
 
4 
A treponemal test that detects a specific subunit of antitreponemal IgM. This test is not yet widely available 
and should not be confused with FTA-ABS. 
